These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 16226058

  • 1. Correction of murine hemophilia A by hematopoietic stem cell gene therapy.
    Moayeri M, Hawley TS, Hawley RG.
    Mol Ther; 2005 Dec; 12(6):1034-42. PubMed ID: 16226058
    [Abstract] [Full Text] [Related]

  • 2. Sustained phenotypic correction of hemophilia a mice following oncoretroviral-mediated expression of a bioengineered human factor VIII gene in long-term hematopoietic repopulating cells.
    Moayeri M, Ramezani A, Morgan RA, Hawley TS, Hawley RG.
    Mol Ther; 2004 Nov; 10(5):892-902. PubMed ID: 15509507
    [Abstract] [Full Text] [Related]

  • 3. Syngeneic transplantation of hematopoietic stem cells that are genetically modified to express factor VIII in platelets restores hemostasis to hemophilia A mice with preexisting FVIII immunity.
    Shi Q, Fahs SA, Wilcox DA, Kuether EL, Morateck PA, Mareno N, Weiler H, Montgomery RR.
    Blood; 2008 Oct 01; 112(7):2713-21. PubMed ID: 18495954
    [Abstract] [Full Text] [Related]

  • 4. Hematopoietic stem cells encoding porcine factor VIII induce pro-coagulant activity in hemophilia A mice with pre-existing factor VIII immunity.
    Doering CB, Gangadharan B, Dukart HZ, Spencer HT.
    Mol Ther; 2007 Jun 01; 15(6):1093-9. PubMed ID: 17387335
    [Abstract] [Full Text] [Related]

  • 5. Functional aspects of factor VIII expression after transplantation of genetically-modified hematopoietic stem cells for hemophilia A.
    Ide LM, Iwakoshi NN, Gangadharan B, Jobe S, Moot R, McCarty D, Doering CB, Spencer HT.
    J Gene Med; 2010 Apr 01; 12(4):333-44. PubMed ID: 20209485
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Factor VIII delivered by haematopoietic stem cell-derived B cells corrects the phenotype of haemophilia A mice.
    Ramezani A, Zweier-Renn LA, Hawley RG.
    Thromb Haemost; 2011 Apr 01; 105(4):676-87. PubMed ID: 21264447
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Sustained transgene expression by human cord blood derived CD34+ cells transduced with simian immunodeficiency virus agmTYO1-based vectors carrying the human coagulation factor VIII gene in NOD/SCID mice.
    Kikuchi J, Mimuro J, Ogata K, Tabata T, Ueda Y, Ishiwata A, Kimura K, Takano K, Madoiwa S, Mizukami H, Hanazono Y, Kume A, Hasegawa M, Ozawa K, Sakata Y.
    J Gene Med; 2004 Oct 01; 6(10):1049-60. PubMed ID: 15386735
    [Abstract] [Full Text] [Related]

  • 11. High-level expression of porcine factor VIII from genetically modified bone marrow-derived stem cells.
    Gangadharan B, Parker ET, Ide LM, Spencer HT, Doering CB.
    Blood; 2006 May 15; 107(10):3859-64. PubMed ID: 16449528
    [Abstract] [Full Text] [Related]

  • 12. Lentivirus-mediated platelet gene therapy of murine hemophilia A with pre-existing anti-factor VIII immunity.
    Kuether EL, Schroeder JA, Fahs SA, Cooley BC, Chen Y, Montgomery RR, Wilcox DA, Shi Q.
    J Thromb Haemost; 2012 Aug 15; 10(8):1570-80. PubMed ID: 22632092
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Partial correction of murine hemophilia A with neo-antigenic murine factor VIII.
    Sarkar R, Gao GP, Chirmule N, Tazelaar J, Kazazian HH.
    Hum Gene Ther; 2000 Apr 10; 11(6):881-94. PubMed ID: 10779165
    [Abstract] [Full Text] [Related]

  • 15. Phenotypic correction and stable expression of factor VIII in hemophilia A mice by embryonic stem cell therapy.
    Wang JJ, Kuang Y, Zhang LL, Shen CL, Wang L, Lu SY, Lu XB, Fei J, Gu MM, Wang ZG.
    Genet Mol Res; 2013 May 13; 12(2):1511-21. PubMed ID: 23765957
    [Abstract] [Full Text] [Related]

  • 16. Efficient production of human FVIII in hemophilic mice using lentiviral vectors.
    Kootstra NA, Matsumura R, Verma IM.
    Mol Ther; 2003 May 13; 7(5 Pt 1):623-31. PubMed ID: 12718905
    [Abstract] [Full Text] [Related]

  • 17. Adenovirus-mediated factor VIII gene expression results in attenuated anti-factor VIII-specific immunity in hemophilia A mice compared with factor VIII protein infusion.
    Bristol JA, Gallo-Penn A, Andrews J, Idamakanti N, Kaleko M, Connelly S.
    Hum Gene Ther; 2001 Sep 01; 12(13):1651-61. PubMed ID: 11535168
    [Abstract] [Full Text] [Related]

  • 18. Heterogeneity of the immune response to adenovirus-mediated factor VIII gene therapy in different inbred hemophilic mouse strains.
    Rawle FE, Shi CX, Brown B, McKinven A, Tinlin S, Graham FL, Hough C, Lillicrap D.
    J Gene Med; 2004 Dec 01; 6(12):1358-68. PubMed ID: 15493040
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Bone marrow stromal cells as targets for gene therapy of hemophilia A.
    Chuah MK, Brems H, Vanslembrouck V, Collen D, VandenDriessche T.
    Hum Gene Ther; 1998 Feb 10; 9(3):353-65. PubMed ID: 9508053
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.